About anidulafun gin
Echinocandin antifungal
Used for
- Treats invasive candidiasis, including candidemia, in adults.
- Treats invasive candidiasis in children aged one month and older.
Usual adult dose
200 mg intravenously on day one, then 100 mg intravenously once daily.
Usual dose in children
Ages 1 month to under 2 years: 3 mg/kg on day one, then 1.5 mg/kg daily. Ages 2 to under 18 years: 3 mg/kg on day one, then 1.5 mg/kg daily; maximum adult doses.
Common side effects
- Diarrhea, nausea, vomiting, or abdominal pain
- Low potassium
- Infusion-related flushing, rash, or breathing difficulty
- Elevated liver enzymes
Important warnings
- Given intravenously by a healthcare professional; infusion reactions can be serious.
- Use caution with liver problems; liver tests may be monitored.
- The child dose depends on age and weight; specialist guidance is needed.
- Treatment duration depends on infection and clinical response.
Pregnancy
Human pregnancy information is limited; use only when clearly needed after weighing potential benefits and risks.
Breastfeeding
It is unknown whether anidulafungin passes into human milk; weigh treatment benefits against potential infant exposure.
Interactions
- Rifampicin may lower anidulafungin exposure; dose adjustment may be needed.
- No clinically important interactions are expected with cyclosporine, tacrolimus, or voriconazole.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.